Human IgG antibody Laboratories manufactures the pcr sars-cov2/test durango reagents distributed by Genprice. The Pcr Sars-Cov2/Test Durango reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact . Other Pcr products are available in stock. Specificity: Pcr Category: Sars-Cov2/Test Group: Durango
Human anti-SARS-CoV2 IgG ELISA Kit (quantitative) |
|
MyBiosource |
10x96-Strip-Wells |
EUR 3900 |
Human anti-SARS-CoV2 IgG ELISA Kit (quantitative) |
|
MyBiosource |
48-Strip-Wells |
EUR 340 |
Human anti-SARS-CoV2 IgG ELISA Kit (quantitative) |
|
MyBiosource |
5x96-Strip-Wells |
EUR 2045 |
Human anti-SARS-CoV2 IgG ELISA Kit (quantitative) |
|
MyBiosource |
96-Strip-Wells |
EUR 455 |
SARS-CoV2-N Antibody |
|
EnoGene |
N/A |
EUR 276.5 |
|
Description: N/A |
SARS-CoV2-N Antibody |
|
EnoGene |
N/A |
EUR 276.5 |
|
Description: N/A |
SARS-Cov2-NP3 Antibody |
|
EnoGene |
N/A |
EUR 276.5 |
|
Description: N/A |
Durango information
Biotinylated SARS COV2 Spike protein S Trimer Recombinant |
|
MBS553736-002mg |
MyBiosource |
0.02mg |
EUR 515 |
Biotinylated SARS COV2 Spike protein S Trimer Recombinant |
|
MBS553736-01mg |
MyBiosource |
0.1mg |
EUR 1435 |
SARS CoV2 Spike S1 Antibody (Clone: ABM3D6.1G6)(13-33aa) |
|
MBS669600-0025mg |
MyBiosource |
0.025mg |
EUR 225 |
SARS CoV2 Spike S1 Antibody (Clone: ABM3D6.1G6)(13-33aa) |
|
MBS669600-01mg |
MyBiosource |
0.1mg |
EUR 445 |
SARS CoV2 Spike S1 Antibody (Clone: ABM3D6.1G6)(13-33aa) |
|
MBS669600-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1990 |
SARS CoV2 Spike S1 Antibody (Clone: ABM4A10.1D3)(239-257aa) |
|
MBS669599-0025mg |
MyBiosource |
0.025mg |
EUR 225 |
SARS CoV2 Spike S1 Antibody (Clone: ABM4A10.1D3)(239-257aa) |
|
MBS669599-01mg |
MyBiosource |
0.1mg |
EUR 445 |
SARS CoV2 Spike S1 Antibody (Clone: ABM4A10.1D3)(239-257aa) |
|
MBS669599-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1990 |
SARS COV2 Spike protein S Recombinant-Fc (AVI tag) |
|
MBS553732-01mg |
MyBiosource |
0.1mg |
EUR 490 |
SARS COV2 Spike protein S Recombinant-Fc (AVI tag) |
|
MBS553732-05mg |
MyBiosource |
0.5mg |
EUR 1570 |
SARS-CoV-2/hRSV/Influenza A/B Real-TM NEW
RT PCR kit for detection of SARS-CoV2 (COVID19), hRSV,Influenza A&B |
|
V448-100FRT |
Sacace Biotechnologies |
96 |
EUR 1046.4 |
SARS-CoV2 RBD |
|
0571-001 |
IBT Bioservices |
100 ug |
EUR 493.75 |
|
|
|
Description: SARS-CoV-2 Receptor Binding Domain |
anti- SARS antibody |
|
FNab07609 |
FN Test |
100µg |
EUR 658.5 |
|
|
|
Description: Antibody raised against SARS |
SARS-CoV-2 Realtime PCR Test Kit (Reaction time 90 mins Lyophilization) EXP 24 months |
|
R205T008B0C2 |
Jiangsu Mole Bioscience Co.,Ltd |
50 Tests/Kit |
Ask for price |
SARS-CoV-2 Ag Rapid Test |
|
HSGIA2200A1COV |
Hi-Senty |
20 Tests/Kit |
Ask for price |
|
Description: The SARS-CoV-2 Ag Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigens in nasal swab specimens from individualswith suspected SARS-CoV-2 infection in conjunction with clinical presentation and the results of other laboratory tests. Results are for the detection of SARS-CoV-2 Antigens. An antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or coinfection with other viruses. The agent detected may not be the definite cause of disease. Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions. Negative results should be treated as presumptive and confirmed with a molecular assay, if necessary for patient management. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19. The SARS-CoV-2 Ag Rapid Test is intended for use by self-testing personnel. |